307 related articles for article (PubMed ID: 8564518)
1. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance.
Engelhardt G; Homma D; Schlegel K; Utzmann R; Schnitzler C
Inflamm Res; 1995 Oct; 44(10):423-33. PubMed ID: 8564518
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2.
Engelhardt G
Br J Rheumatol; 1996 Apr; 35 Suppl 1():4-12. PubMed ID: 8630636
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
[TBL] [Abstract][Full Text] [Related]
4. Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings.
Engelhardt G; Bögel R; Schnitzler C; Utzmann R
Biochem Pharmacol; 1996 Jan; 51(1):29-38. PubMed ID: 8534265
[TBL] [Abstract][Full Text] [Related]
5. Comparison of analgesic and anti-inflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: pharmacokinetic parameters after topical application.
Gupta SK; Bansal P; Bhardwaj RK; Jaiswal J; Velpandian T
Skin Pharmacol Appl Skin Physiol; 2002; 15(2):105-11. PubMed ID: 11867967
[TBL] [Abstract][Full Text] [Related]
6. Meloxicam.
Fleischmann R; Iqbal I; Slobodin G
Expert Opin Pharmacother; 2002 Oct; 3(10):1501-12. PubMed ID: 12387696
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4'-isomer.
Pairet M; van Ryn J; Schierok H; Mauz A; Trummlitz G; Engelhardt G
Inflamm Res; 1998 Jun; 47(6):270-6. PubMed ID: 9683035
[TBL] [Abstract][Full Text] [Related]
8. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.
Futaki N; Yoshikawa K; Hamasaka Y; Arai I; Higuchi S; Iizuka H; Otomo S
Gen Pharmacol; 1993 Jan; 24(1):105-10. PubMed ID: 8482483
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
[TBL] [Abstract][Full Text] [Related]
10. [Meloxicam (Mobic): a review of its pharmacological and clinical profile].
Ogino K; Saito K; Osugi T; Satoh H
Nihon Yakurigaku Zasshi; 2002 Dec; 120(6):391-7. PubMed ID: 12528470
[TBL] [Abstract][Full Text] [Related]
11. Effects of lornoxicam, piroxicam, and meloxicam in a model of thermal hindpaw hyperalgesia induced by formalin injection in rat tail.
Bianchi M; Panerai AE
Pharmacol Res; 2002 Feb; 45(2):101-5. PubMed ID: 11846620
[TBL] [Abstract][Full Text] [Related]
12. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
[TBL] [Abstract][Full Text] [Related]
13. Meloxicam.
Noble S; Balfour JA
Drugs; 1996 Mar; 51(3):424-30; discussion 431-32. PubMed ID: 8882380
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory, analgesic and anti-pyretic effects of d-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid (M-5011), a new non-steroidal anti-inflammatory drug, in rats and guinea pigs.
Kido H; Murakami N; Ito A; Kimura K; Kodera N; Doi T; Naruse T
Jpn J Pharmacol; 1998 Jan; 76(1):75-86. PubMed ID: 9517407
[TBL] [Abstract][Full Text] [Related]
15. Investigations on analgesic, anti-inflammatory and ulcerogenic potential of meloxicam solid dispersion prepared with skimmed milk.
Mishra DN; Vijaya Kumar SG
Yakugaku Zasshi; 2006 Jul; 126(7):495-8. PubMed ID: 16819271
[TBL] [Abstract][Full Text] [Related]
16. Meloxicam complexation with beta-cyclodextrin: influence on the anti-inflammatory and ulcerogenic activity.
Baboota S; Agarwal SP
Pharmazie; 2003 Jan; 58(1):73-4. PubMed ID: 12622261
[No Abstract] [Full Text] [Related]
17. Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs.
Rainsford KD; Skerry TM; Chindemi P; Delaney K
Vet Res Commun; 1999 Mar; 23(2):101-13. PubMed ID: 10359154
[TBL] [Abstract][Full Text] [Related]
18. Analgesic, antiinflammatory, and ulcerogenic studies of meloxicam solid dispersion prepared with polyethylene glycol 6000.
Vijaya Kumar SG; Mishra DN
Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):419-22. PubMed ID: 17003846
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological activity of FPP028 (2-phenylpyrazolo-4-ethyl-4,7-dihydro [1,5a]pyrimidin-7-one) a new non-steroid anti-inflammatory agent.
Pirisino R; Bianchini F; Banchelli G; Ignesti G; Raimondi L; Pecori-Vettori L; Rafanelli D
Pharmacol Res Commun; 1986 Mar; 18(3):241-56. PubMed ID: 3487802
[TBL] [Abstract][Full Text] [Related]
20. Meloxicam: selective COX-2 inhibition in clinical practice.
Furst DE
Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):21-7. PubMed ID: 9219316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
